CTLA4 and glioblastoma: As an abundant population in the TIME of GBM, they contribute significantly to its immunosuppressive character and are characterized by a CD3+/CD4+/CD25high/CD127−/low/FoxP3high/CD45RA−/CD45R0+/CCR7+/CD62L−/CTLA4+ immunophenotype.